31Oct/100
US approves Novartis brain tumour drug
Swiss pharmaceutical company Novartis said Saturday that the US Food and Drug Administration had approved a drug for treating certain benign brain tumours which previously required surgery.
Swiss pharmaceutical company Novartis said Saturday that the US Food and Drug Administration had approved a drug for treating certain benign brain tumours which previously required surgery.